Hester Biosciences has informed that Board of Directors, in their Meeting held today, have approved the unaudited standalone and consolidated financial results for the for the quarter and nine months period ended 31 December 2023, as recommended by Audit Committee. It has attached the approved unaudited standalone and consolidated financial results and limited review reports, A Press Release issued in this regard We will be publishing an extract of the results in the newspaper as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board Meeting commenced at 11:17 am (IST) and concluded at 12:05 pm (IST).
The above information is a part of company’s filings submitted to BSE.
